Ordered BPC + TB500 and will be back
The primary reasons for exclusion were withdrawal from follow-up at the participants discretion, treatment discontinuation due to nausea, drug supply issues, cholangiocarcinoma, pancreatitis, and treatment cessation at a non-participating institution ( Figure 1 )
GLP-1 weight loss users significantly reduce their unit volume of food purchasing (-8.6%) and more revealingly of alcohol (-14.5%).[18] More recent, less accurate, survey research on GLP-1 weight-loss drug users from September 2023 suggests the following rank order of reported decreased consumption that features a big impact to the QSR and candy industries: Fast Food (77%) Pizza restaurants (74%) Confectionery (72%) Carbonated/sugary drinks (70%) Cookies/baked products (69%) Alcohol (66%)[19] Top foods where users report an increase in consumption: Fruits and vegetables 54% Weight-loss management foods (44%) Poultry and fish (38%)[20] GLP-1 drugs, unlike bariatric surgery, appear to have a strong effect on muting intrinsic desire for compulsive (and impulsive) eating and drinking
Upcoming Medical Procedures If you have a scheduled surgery or a diagnostic test like a colonoscopy, your healthcare provider may ask you to adjust or pause your GLP-1 or GIP medication
Of note, E138 1.33b R in GLP-1R and R131 1.33b E in GIPR modestly increased and decreased the potency of retatrutide, respectively, indicating the receptor-specific adaptability of peptide recognition at this site (Fig
